Cite
Takenaka W, Takahashi Y, Tamari K, et al. Radiation Dose Escalation is Crucial in Anti-CTLA-4 Antibody Therapy to Enhance Local and Distant Antitumor Effect in Murine Osteosarcoma. Cancers (Basel). 2020;12(6)doi: 10.3390/cancers12061546.
Takenaka, W., Takahashi, Y., Tamari, K., Minami, K., Katsuki, S., Seo, Y., Isohashi, F., Koizumi, M., & Ogawa, K. (2020). Radiation Dose Escalation is Crucial in Anti-CTLA-4 Antibody Therapy to Enhance Local and Distant Antitumor Effect in Murine Osteosarcoma. Cancers, 12(6), . https://doi.org/10.3390/cancers12061546
Takenaka, Wataru, et al. "Radiation Dose Escalation is Crucial in Anti-CTLA-4 Antibody Therapy to Enhance Local and Distant Antitumor Effect in Murine Osteosarcoma." Cancers vol. 12,6 (2020). doi: https://doi.org/10.3390/cancers12061546
Takenaka W, Takahashi Y, Tamari K, Minami K, Katsuki S, Seo Y, Isohashi F, Koizumi M, Ogawa K. Radiation Dose Escalation is Crucial in Anti-CTLA-4 Antibody Therapy to Enhance Local and Distant Antitumor Effect in Murine Osteosarcoma. Cancers (Basel). 2020 Jun 12;12(6). doi: 10.3390/cancers12061546. PMID: 32545427; PMCID: PMC7352693.
Copy
Download .nbib
